28 times may be the FDA requirement for producers of multi-use vials to establish their bacteriostatic maintains efficacy. This bare minimum requirement will become the de facto normal.Tom writes about GLP-1 protocols because he could not discover apparent solutions when he desired them. Soon after months of digging via medical trials, FDA filings,